Healthcare >> CEO Interviews >> January 10, 2001

Alfred Mann – Minimed Inc (mnmd)

ALFRED E. MANN has served as Chairman of the Board and Chief Executive Officer of MiniMed, Inc., and its predecessor's partnership since its founding in 1985. Since 1994, Mr. Mann has also served as Chairman and CEO of Advanced Bionics Corporation, which is the successor to the electrostimulation business segment of MiniMed's predecessor. He is also the Chairman of Medical Research Group, which is developing a prosthetic artificial pancreas. Mr. Mann is also Chairman of Second Sight LLC, which is developing a visual prosthesis for the blind; CTL Immunotherapy Inc., which is developing therapeutic vaccines for cancer and other chronic diseases; Allecure, which is developing therapies to control allergies and asthma; and Pharmaceutical Discovery Corporation, which has developed an encapsulation capability for pulmonary and oral delivery of proteins and peptides. Mr. Mann also is Chairman of the Board of Directors at the Alfred E. Mann Foundation and the Alfred E. Mann Institute for Biomedical Research at the University of Southern California, both not-for-profit research and development corporations devoted to the development of medical devices and associated technology. From 1985 to September 1992, Mr. Mann was also President and CEO of Siemens-Pacesetter, Inc., a manufacturer of cardiac pacemakers. Mr. Mann founded, and from 1972 until 1985, was Chairman of the Board and CEO of Pacesetter Systems, Inc., a California corporation and predecessor of Siemens-Pacesetter, Inc. Prior to 1972, he was President of Spectrolab, an electro-optical and aerospace systems company, and Heliotek, a semiconductor and electro-optical components manufacturer. Mr. Mann founded these companies in 1956 and 1960, respectively; they were sold to Textron Inc. in 1960. Mr. Mann is also Chairman of the Southern California Biomedical Council, a not-for-profit organization devoted to expanding opportunities for the biomedical industry and institutions, especially in the greater Los Angeles region. Mr. Mann holds an MS degree in Physics from the University of California, Los Angeles. Profile
TWST: Could we begin with a brief background summary and overview of

MiniMed?

Mr. Mann: MiniMed is a company primarily involved in chronic disease

management, with a principal focus today on